Listed MedTech TruSpine scrambles for survival
Listed MedTech TruSpine has reported another year of losses as it scrambles for survival. For the year ended 29th March 2023, the pre-revenue company lost 拢853,000 before tax – compared with 拢941,000 in 2022 – with an R&D tax credit of 拢199,000 taking loss after tax to 拢654,000. The firm stated this morning: 鈥淭he group … Continue reading Listed MedTech TruSpine scrambles for survival
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed